253 related articles for article (PubMed ID: 11473207)
21. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
[TBL] [Abstract][Full Text] [Related]
22. Radioiodine I-131 therapy in the management of differentiated thyroid carcinoma: a review of 202 patients.
Chen WL; Guan SI; Huang WS
J Formos Med Assoc; 1993 Jul; 92(7):623-31. PubMed ID: 7904498
[TBL] [Abstract][Full Text] [Related]
23. Differentiated thyroid cancer.
Kumar A; Bal CS
Indian J Pediatr; 2003 Sep; 70(9):707-13. PubMed ID: 14620185
[TBL] [Abstract][Full Text] [Related]
24. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
Engel U; Kucharski A; Zornig C
Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
[TBL] [Abstract][Full Text] [Related]
25. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
26. Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents.
Papendieck P; Gruñeiro-Papendieck L; Venara M; Acha O; Maglio S; Bergadá I; Chiesa A
J Pediatr Endocrinol Metab; 2011; 24(9-10):743-8. PubMed ID: 22145467
[TBL] [Abstract][Full Text] [Related]
27. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M
Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
29. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
[TBL] [Abstract][Full Text] [Related]
30. Cancer of the thyroid in children and adolescents.
Segal K; Arad-Cohen A; Mechlis S; Lubin E; Feinmesser R
Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):525-8. PubMed ID: 9466063
[TBL] [Abstract][Full Text] [Related]
31. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Cetani F; Miccoli P; Mancusi F; Ceccarelli C; Lippi F; Martino E; Pinchera A
World J Surg; 1994; 18(4):600-4. PubMed ID: 7725751
[TBL] [Abstract][Full Text] [Related]
32. Survival of differentiated thyroid carcinoma studied in 500 patients.
Lerch H; Schober O; Kuwert T; Saur HB
J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
[TBL] [Abstract][Full Text] [Related]
33. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
34. Thyroid carcinoma in children and adolescents.
Danese D; Gardini A; Farsetti A; Sciacchitano S; Andreoli M; Pontecorvi A
Eur J Pediatr; 1997 Mar; 156(3):190-4. PubMed ID: 9083757
[TBL] [Abstract][Full Text] [Related]
35. Management of differentiated thyroid carcinomas.
Fernández-Vañes L; Llorente JL; García-Cabo P; Menéndez M; Pedregal D; Rodrigo JP; López F
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(4):200-206. PubMed ID: 29880224
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary metastases in children and young adults with differentiated thyroid cancer.
Vassilopoulou-Sellin R; Klein MJ; Smith TH; Samaan NA; Frankenthaler RA; Goepfert H; Cangir A; Haynie TP
Cancer; 1993 Feb; 71(4):1348-52. PubMed ID: 8435810
[TBL] [Abstract][Full Text] [Related]
37. [Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma].
Díez JJ; Grande E; Iglesias P
Med Clin (Barc); 2015 Jan; 144(1):35-41. PubMed ID: 24613061
[TBL] [Abstract][Full Text] [Related]
38. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
39. Follow-up and results in patients with differentiated thyroid carcinoma in Castilla-La Mancha (2001-2015). The CADIT-CAM study.
Sastre Marcos J; Aznar S; Álvarez V; Torres B; Delgado M; González J; Quiroga I
Endocrinol Diabetes Nutr (Engl Ed); 2019 Mar; 66(3):164-172. PubMed ID: 30583968
[TBL] [Abstract][Full Text] [Related]
40. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]